Company / Cost of Revenue
Evolent Health, Inc. Cost of Revenue History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$1.5B
FY2025
5-year range
$657.6M / $2.2B
FY2021-FY2025
Trend
-32.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$1.5B in FY2025 with a 3-year CAGR of +12.6%.
Remained stable around $1.5B over the past 2 years.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +12.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +12.6%, indicating consistent growth.
- In FY2025, cost of revenue decreased 32.5% year-over-year.
- Peak cost of revenue was recorded in FY2024.
- Lowest cost of revenue in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.84 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.5B | -32.5% |
| FY2024 | $2.2B | +45.5% |
| FY2023 | $1.5B | +45.2% |
| FY2022 | $1.0B | +57.5% |
| FY2021 | $657.6M | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026